Rie Kondo

Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis

Satoshi Watanabe, Junta Tanaka, Takeshi Ota et al. · BMC Cancer · 2011 · 392 citations · Full text

Cooperation of NF-κB2/p100 Activation and the PDZ Domain Binding Motif Signal in Human T-Cell Leukemia Virus Type 1 (HTLV-1) Tax1 but Not HTLV-2 Tax2 Is Crucial for Interleukin-2-Independent Growth Transformation of a T-Cell Line

Masaya Higuchi, Chikako Tsubata, Rie Kondo et al. · Journal of Virology · 2007 · 92 citations · Full text

Htlv-2 Tax2, Htlv-1 Tax1, T-cell Line +15

Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors

Ko Sato, Satoshi Watanabe, Aya Ohtsubo et al. · BMC Cancer · 2016 · 54 citations · Full text

Identification of a novel motif responsible for the distinctive transforming activity of human T-cell leukemia virus (HTLV) type 1 Tax1 protein from HTLV-2 Tax2

Toshiyuki Shoji, Masaya Higuchi, Rie Kondo et al. · Retrovirology · 2009 · 48 citations · Full text

A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung Cancer

Rie Kondo, Satoshi Watanabe, Satoshi Shoji et al. · Oncology · 2018 · 43 citations